Article
(Reuters) - The costs linked to heart failure in the United States are expected to more than double within the next two decades as the population ages and treatments help patients with the disease live longer, a study released on Wednesday found.
The American Heart Association predicted that the number of Americans with the fatal condition will grow to 8 million in 2030 from about 5 million in 2012. The costs to treat them will rise to $53 billion from $21 billion, the group said in its analysis.
If indirect costs related to heart failure are included, such as lost productivity and wages when patients become too sick to work, the total costs jump to $70 billion from $31 billion over the 18-year period, its study showed.
Read the full story here: http://reut.rs/Y6uH8X
Source: Reuters
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.